Archive for January 9th, 2022

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

09-Jan-2022 Intellasia | PR Newswire Asia | 9:09 AM

TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the [...] » More